Myeloid-derived suppressor cells exhibit distinct characteristics in bone marrow and blood of individuals with diffuse large B-cell lymphoma.

Saved in:
Bibliographic Details
Title: Myeloid-derived suppressor cells exhibit distinct characteristics in bone marrow and blood of individuals with diffuse large B-cell lymphoma.
Authors: Efstratiou P; Laboratory of Hematology, Division of Laboratory Medicine, School of Medicine, University of Crete and University Hospital of Heraklion, Heraklion, Greece., Damianaki A; Laboratory of Hematology, Division of Laboratory Medicine, School of Medicine, University of Crete and University Hospital of Heraklion, Heraklion, Greece., Kavidopoulou A; Laboratory of Hematology, Division of Laboratory Medicine, School of Medicine, University of Crete and University Hospital of Heraklion, Heraklion, Greece., Ioannidou P; Laboratory of Hematology, Division of Laboratory Medicine, School of Medicine, University of Crete and University Hospital of Heraklion, Heraklion, Greece., Markaki E; Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, School of Medicine, University of Crete, Heraklion, Greece., Skianis IM; Laboratory of Hematology, Division of Laboratory Medicine, School of Medicine, University of Crete and University Hospital of Heraklion, Heraklion, Greece., Tsagliotis E; Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Greece., Kaliafentaki V; Laboratory of Hematology, Division of Laboratory Medicine, School of Medicine, University of Crete and University Hospital of Heraklion, Heraklion, Greece., Mattheakakis A; Laboratory of Hematology, Division of Laboratory Medicine, School of Medicine, University of Crete and University Hospital of Heraklion, Heraklion, Greece., Ximeri M; Laboratory of Hematology, Division of Laboratory Medicine, School of Medicine, University of Crete and University Hospital of Heraklion, Heraklion, Greece., Manouras E; Laboratory of Hematology, Division of Laboratory Medicine, School of Medicine, University of Crete and University Hospital of Heraklion, Heraklion, Greece., Lavigne M; Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Greece., Verginis P; Laboratory of Hematology, Division of Laboratory Medicine, School of Medicine, University of Crete and University Hospital of Heraklion, Heraklion, Greece.; Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, School of Medicine, University of Crete, Heraklion, Greece.; Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Greece., Kalpadakis C; Laboratory of Hematology, Division of Laboratory Medicine, School of Medicine, University of Crete and University Hospital of Heraklion, Heraklion, Greece.
Source: Frontiers in medicine [Front Med (Lausanne)] 2025 Jan 29; Vol. 11, pp. 1515097. Date of Electronic Publication: 2025 Jan 29 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2296-858X
DOI:10.3389/fmed.2024.1515097